<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Med Case Rep</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Med Case Rep</journal-id>
      <journal-title-group>
        <journal-title>Journal of Medical Case Reports</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1752-1947</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27103315</article-id>
      <article-id pub-id-type="pmc">4841063</article-id>
      <article-id pub-id-type="publisher-id">885</article-id>
      <article-id pub-id-type="doi">10.1186/s13256-016-0885-8</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Optic nerve sheath meningioma detected by single- photon emission computed tomography/computed tomography somatostatin receptor scintigraphy: a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Nussbaum-Hermassi</surname>
            <given-names>Lucie</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ahle</surname>
            <given-names>Guido</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zaenker</surname>
            <given-names>Chistophe</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Duca</surname>
            <given-names>Camelia</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Namer</surname>
            <given-names>Izzie Jacques</given-names>
          </name>
          <address>
            <phone>+33.388.12.75.50</phone>
            <email>izzie.jacques.namer@chru-strasbourg.fr</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff4"/>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <aff id="Aff1"><label/>Service de Biophysique et M&#xE9;decine Nucl&#xE9;aire, H&#xF4;pital de Hautepierre, H&#xF4;pitaux Universitaires de Strasbourg, 1, avenue Moli&#xE8;re, 67098 Strasbourg, Cedex 09 France </aff>
        <aff id="Aff2"><label/>Service de Neurologie, H&#xF4;pitaux Civils de Colmar, Colmar, France </aff>
        <aff id="Aff3"><label/>Service de Radiologie, H&#xF4;pitaux Civils de Colmar, Colmar, France </aff>
        <aff id="Aff4"><label/>ICube, Universit&#xE9; de Strasbourg/CNRS (UMR 7357), Strasbourg, France </aff>
        <aff id="Aff5"><label/>F&#xE9;d&#xE9;ration de M&#xE9;decine Translationnelle de Strasbourg (FMTS), Facult&#xE9; de M&#xE9;decine, Strasbourg, France </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>22</day>
        <month>4</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>22</day>
        <month>4</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>10</volume>
      <elocation-id>96</elocation-id>
      <history>
        <date date-type="received">
          <day>29</day>
          <month>4</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>3</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Nussbaum-Hermassi et al. 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Optic nerve sheath meningiomas account for only 2 % of orbital lesions and 42 % of optic nerve tumors. Diagnosis remains difficult because histologic confirmation carries a high risk of visual loss. Therefore, a less invasive and specific diagnostic method for differentiating optic nerve sheath meningiomas from other optic nerve lesions is needed to overcome the limitations of computed tomography and magnetic resonance imaging, and make the best individualized treatment decision. This case is a good illustration of the clinical and imaging difficulties inherent in this rare tumor, which may be hard to differentiate from other causes.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>A 51-year-old Caucasian woman developed a central scotoma, visual loss, and abnormal visual evoked potentials. The first magnetic resonance imaging scan classified the optic nerve damage as retrobulbar optic neuritis. After magnetic resonance imaging follow-up at 3 months, a negative lumbar puncture and biological workup, and clinical worsening, an optic nerve sheath meningioma was suspected. We confirmed this diagnosis with <sup>111</sup>In-pentetreotide single-photon emission computed tomography, which is able to bind with very high affinity to somatostatin receptor subtype 2 expressed on meningiomas.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>In the diagnosis of optic nerve sheath meningiomas, [<sup>111</sup>In]-pentetreotide single-photon emission computed tomography-fused magnetic resonance imaging is a valuable additional tool, optimizing the diagnosis and obviating the need for a more invasive procedure.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Optic nerve sheath meningioma</kwd>
        <kwd>SPECT/CT</kwd>
        <kwd>Somatostatin receptor</kwd>
        <kwd>Pentetreotide</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Optic nerve sheath meningiomas (ONSMs) account for 2 % of orbital lesions and are the second most common optic nerve tumors, after optic nerve gliomas [<xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR4">4</xref>]. Clinically, optic nerve tumors closely mimic optic neuritis with painless unilateral vision impairment [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Diagnosis remains difficult because histologic confirmation carries a high risk of visual loss. Therefore, a less invasive and specific diagnostic method for differentiating ONSMs from other optic nerve tumors is crucial for individualized treatment decisions. Meningiomas intensely express the somatostatin receptors [<xref ref-type="bibr" rid="CR6">6</xref>&#x2013;<xref ref-type="bibr" rid="CR13">13</xref>], and receptor-negative cases are extremely rare [<xref ref-type="bibr" rid="CR8">8</xref>]. Since somatostatin receptor scintigraphy has applications in the differential diagnosis between ONSMs and other orbital lesions, magnetic resonance imaging (MRI) is particularly valuable for evaluation of orbital neoplasms because it provides critical anatomic information on the ocular structures involved, perineural spread and intracranial extension [<xref ref-type="bibr" rid="CR3">3</xref>].</p>
      <p>We present a case of ONSM diagnosed using [<sup>111</sup>In]-pentetreotide single-photon emission computed tomography/computed tomography (SPECT/CT) in a patient initially followed for a diagnosis of optic neuritis.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A 51-year-old Caucasian woman initially consulted for right visual loss (2/10, with corrective lenses) and central scotoma demonstrated with perimetry. Visual evoked potentials confirmed the altered conduction of the right optic nerve. In the absence of any other obvious neurologic symptoms and signs, optic neuritis was suspected. An initial MRI scan showed right tortuous optic nerve enlargement with a peripherally increased signal on fluid-attenuated inversion recovery (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1b</xref>) and on coronal T2-weighted fat-suppressed (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1f</xref>) sequences. Therefore, uniform contrast enhancement (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1a</xref> and <xref rid="Fig1" ref-type="fig">e</xref>) affected the last third of the nerve.<fig id="Fig1"><label>Fig. 1</label><caption><p>Multimodal imaging: matched transverse, postcontrast spin-echo T1-weighted (<bold>a</bold>), and fluid-attenuated inversion recovery (<bold>b</bold>) 1.5-T MRI scans, fused MRI/SPECT (<bold>c</bold>) and <sup>111</sup>In-pentetreotide SPECT images (<bold>d</bold>). Transverse postcontrast gradient echo T1-weighted MRI scan (<bold>e</bold>) showing the location of coronal slices, and three-level coronal T2-weighted fat-suppressed MRI scan (<bold>f</bold>), fused MRI/SPECT image (<bold>g</bold>) and [<sup>111</sup>In]-pentetreotide SPECT image (<bold>h</bold>). MRI scan showed right tortuous optic nerve enlargement (<bold>b</bold>, <italic>dotted arrow</italic>), with a peripherally increased signal on fluid-attenuated inversion recovery (<bold>b</bold>, <italic>dotted arrow</italic>) and on coronal T2-weighted fat-suppressed sequences (<bold>f</bold>, <italic>dotted arrow</italic>). Therefore, uniform contrast enhancement (<bold>a</bold> and <bold>e</bold>, <italic>solid arrows</italic>) affected the last third of the nerve corresponding to an intense [<sup>111</sup>In]-pentetreotide uptake (<bold>d</bold> and <bold>h</bold>). The asterisk (*) shows the physiological uptake of [<sup>111</sup>In]-pentetreotide in the pituitary (<bold>c</bold> and <bold>d</bold>)</p></caption><graphic xlink:href="13256_2016_885_Fig1_HTML" id="MO1"/></fig></p>
      <p>Three months later, follow-up MRI demonstrated the persistent signal abnormalities on MRI. A comprehensive biological workup including lumbar puncture &#x2013; initially refused by the patient &#x2013; showed no abnormal results, and an ONSM was suspected.</p>
      <p>SPECT/CT was performed 24 h after injection of 180 MBq [<sup>111</sup>In]-pentetreotide and showed an intense uptake in the last third of the intraorbital right optic nerve (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1d</xref> and <xref rid="Fig1" ref-type="fig">h</xref>) corresponding to the contrast enhancement on the MRI scan. After this confirmation, she was referred to the radiotherapy center for stereotaxic radiotherapy. A treatment consisting in 30 sessions of stereotaxic radiotherapy was planned. Our patient received a total of 54 Gy by photons of 6 MeV (1.8 Gy per session), which was well tolerated. The 1-year clinical follow-up was positive with disappearance of the Marcus Gunn pupil sign, better visual acuity (7/10, with corrective lenses), and stability on MRI imaging.</p>
      <sec id="Sec3">
        <title>Discussion</title>
        <p>Although meningiomas are common intracranial tumors, ONSMs as a specific subset are infrequent, accounting for only 1&#x2013;2 % of all meningiomas [<xref ref-type="bibr" rid="CR14">14</xref>]. Since morphological imaging techniques have their limitations in differentiating meningiomas from other tumors of the optic pathway [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>], an alternative method was added to detect whether this lesion expressed somatostatin receptors. Thus SPECT/CT or positron emission tomography/computed tomography (PET/CT) imaging with somatostatin analog radiotracers are highly effective methods for detection of meningiomas [<xref ref-type="bibr" rid="CR6">6</xref>&#x2013;<xref ref-type="bibr" rid="CR13">13</xref>].</p>
        <p>In accordance with a few studies on ONSMs [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>], the case reported herein showed an intense uptake of [<sup>111</sup>In]-pentetreotide in the last third of the intraorbital right optic nerve (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1c</xref>, <xref rid="Fig1" ref-type="fig">d</xref>, <xref rid="Fig1" ref-type="fig">g</xref> and <xref rid="Fig1" ref-type="fig">h</xref>), as well as physiological pituitary uptake (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1c</xref> and <xref rid="Fig1" ref-type="fig">d</xref>). This radiotracer presents a very high affinity for somatostatin receptor subtype 2 with high sensitivity and specificity, as well as [<sup>111</sup>In]-octreotide. There have also been reports on using somatostatin to treat intracranial meningiomas and monitor the efficacy of the treatment [<xref ref-type="bibr" rid="CR16">16</xref>].</p>
        <p>Consequently, this imaging technique provides good proof so that the exact origin of certain optic nerve tumors can be identified, especially and specifically in cases of very small tumors, in order to avoid biopsy and give the best treatment available quickly. In the majority of ONSMs involving the orbit, complete surgical resection is not possible and the results of surgical decompression are poor, despite the natural progression of diseases with progressive visual loss [<xref ref-type="bibr" rid="CR15">15</xref>]. The diagnosis of ONSM is a crucial one, because modern surgical and/or radiotherapy approaches at an early stage may allow total resection and improve the chances of preserving vision [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR17">17</xref>&#x2013;<xref ref-type="bibr" rid="CR19">19</xref>]. For this reason, our patient could be treated with the best adapted procedure, resulting in better visual acuity. This technique with multimodal imaging provided positive identification rapidly, and our patient was spared more permanent visual damage or intracranial growth. A surgical approach was not adapted and presented a risk in this case due to the location and the small size.</p>
        <p>This case supports other studies [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>] that have demonstrated a high [<sup>111</sup>In]-pentetreotide uptake by ONSMs, and shows the importance of making an early and noninvasive diagnosis compared to other orbital lesions, that is, optic nerve gliomas, optic nerve inflammation, non-Hodgkin lymphomas, vascular lesions, and sarcoidosis [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. In the present case, it was the most effective method to reverse the initial diagnosis of optic neuritis.</p>
      </sec>
    </sec>
    <sec id="Sec4">
      <title>Conclusions</title>
      <p>In the diagnosis of ONSMs, somatostatin receptor subtype 2 detected with [<sup>111</sup>In]-pentetreotide SPECT/CT fused on MRI is a valuable additional tool, optimizing the diagnosis and obviating the need for a more invasive procedure.</p>
    </sec>
    <sec id="Sec5">
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>CT</term>
          <def>
            <p>computed tomography</p>
          </def>
        </def-item>
        <def-item>
          <term>MRI</term>
          <def>
            <p>magnetic resonance imaging</p>
          </def>
        </def-item>
        <def-item>
          <term>ONMS</term>
          <def>
            <p>optic nerve sheath meningiomas</p>
          </def>
        </def-item>
        <def-item>
          <term>PET/CT</term>
          <def>
            <p>positron emission tomography/computed tomography</p>
          </def>
        </def-item>
        <def-item>
          <term>SPECT/CT</term>
          <def>
            <p>single photon emission computed tomography/computed tomography</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>LNH and IJN made the nuclear medicine diagnosis and drafted the manuscript. GA and CZ followed up and managed the patient, and CD performed the MRI. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>The assistance of the neurology, radiology, and nuclear medicine units in acquiring data is gratefully acknowledged.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shields</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Shields</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Scartozzi</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Survey of 1264 patients with orbital tumors and simulating lesions: the 2002 Montgomery Lecture, part 1</article-title>
          <source>Ophthalmology</source>
          <year>2002</year>
          <volume>2004</volume>
          <issue>111</issue>
          <fpage>997</fpage>
          <lpage>1008</lpage>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tailor</surname>
              <given-names>TD</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dalley</surname>
              <given-names>DW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Orbital neoplasm in adults: clinical, radiologic, and pathologic review</article-title>
          <source>Radiographics.</source>
          <year>2013</year>
          <volume>33</volume>
          <fpage>1739</fpage>
          <lpage>58</lpage>
          <pub-id pub-id-type="doi">10.1148/rg.336135502</pub-id>
          <pub-id pub-id-type="pmid">24108560</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saeed</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rootman</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Nugent</surname>
              <given-names>RA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Optic nerve sheath meningiomas</article-title>
          <source>Ophthalmology.</source>
          <year>2003</year>
          <volume>110</volume>
          <fpage>2019</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="doi">10.1016/S0161-6420(03)00787-5</pub-id>
          <pub-id pub-id-type="pmid">14522782</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rebika</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bonnin</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>K&#xE9;m&#xE9;ny</surname>
              <given-names>JL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Apropos of 5 cases of optic nerve tumors diagnosed during a 6-year-period</article-title>
          <source>J Fr Ophtalmol.</source>
          <year>2015</year>
          <volume>38</volume>
          <fpage>13</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jfo.2014.06.011</pub-id>
          <pub-id pub-id-type="pmid">25542442</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Toosy</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Mason</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>Optic neuritis</article-title>
          <source>Lancet Neurol.</source>
          <year>2014</year>
          <volume>13</volume>
          <fpage>83</fpage>
          <lpage>99</lpage>
          <pub-id pub-id-type="doi">10.1016/S1474-4422(13)70259-X</pub-id>
          <pub-id pub-id-type="pmid">24331795</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saeed</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Tanck</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Freling</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Somatostatin receptor scintigraphy for optic nerve sheath meningiomas</article-title>
          <source>Ophthalmology.</source>
          <year>2009</year>
          <volume>116</volume>
          <fpage>1581</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ophtha.2009.02.004</pub-id>
          <pub-id pub-id-type="pmid">19500849</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klingenstein</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Haug</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ga-68-DOTA-TATE PET/CT for discrimination of tumors of the optic pathway</article-title>
          <source>Orbit.</source>
          <year>2015</year>
          <volume>34</volume>
          <fpage>16</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="doi">10.3109/01676830.2014.959185</pub-id>
          <pub-id pub-id-type="pmid">25264824</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henze</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schuhmacher</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hipp</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>PET imaging of somatostatin receptors using [<sup>68</sup>GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas</article-title>
          <source>J Nucl Med.</source>
          <year>2001</year>
          <volume>42</volume>
          <fpage>1053</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">11438627</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bural</surname>
              <given-names>GG</given-names>
            </name>
            <name>
              <surname>Lieberman</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Mountz</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Use of <sup>111</sup>In-pentetreotide scan in a subject with treatment refractory atypical meningioma</article-title>
          <source>Clin Nucl Med.</source>
          <year>2014</year>
          <volume>39</volume>
          <fpage>342</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1097/RLU.0000000000000326</pub-id>
          <pub-id pub-id-type="pmid">24445268</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rahman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Raja</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ehni</surname>
              <given-names>BL</given-names>
            </name>
          </person-group>
          <article-title>False-positive indium-111 pentetreotide scan for recurrent meningioma due to radiation fibrosis</article-title>
          <source>Clin Nucl Med.</source>
          <year>2011</year>
          <volume>36</volume>
          <fpage>43</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1097/RLU.0b013e3181feedab</pub-id>
          <pub-id pub-id-type="pmid">21157209</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leondi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Valotassiou</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Koutsikos</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Multiple meningiomas</article-title>
          <source>Clin Nucl Med.</source>
          <year>2005</year>
          <volume>30</volume>
          <fpage>361</fpage>
          <lpage>2</lpage>
          <pub-id pub-id-type="doi">10.1097/01.rlu.0000159910.88512.65</pub-id>
          <pub-id pub-id-type="pmid">15827417</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Afshar-Oromieh</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Giesel</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>Linhart</surname>
              <given-names>HG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Detection of cranial meningiomas: comparison of <sup>68</sup>Ga-DOTATOC PET/CT and contrast-enhanced MRI</article-title>
          <source>Eur J Nucl Med Mol Imaging.</source>
          <year>2012</year>
          <volume>39</volume>
          <fpage>1409</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="doi">10.1007/s00259-012-2155-3</pub-id>
          <pub-id pub-id-type="pmid">22669255</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Afshar-Oromieh</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Kratochwil</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comparison of <sup>68</sup>Ga-DOTATOC PET/CT and PET/MRI hybrid systems in patients with cranial meningioma: initial results</article-title>
          <source>Neuro Oncol.</source>
          <year>2015</year>
          <volume>17</volume>
          <fpage>312</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1093/neuonc/nou131</pub-id>
          <pub-id pub-id-type="pmid">25008094</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smee</surname>
              <given-names>RI</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Optic nerve sheath meningiomas &#x2013; non-surgical treatment</article-title>
          <source>Clin Oncol.</source>
          <year>2009</year>
          <volume>21</volume>
          <fpage>8</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1016/j.clon.2008.10.010</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jackson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Patankar</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Laitt</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <article-title>Intracanilicular optic nerve meningioma: a serious diagnostic pitfall</article-title>
          <source>AJNR Am J Neuroradiol.</source>
          <year>2003</year>
          <volume>24</volume>
          <fpage>1167</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="pmid">12812948</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chamberlain</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Glantz</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Fadul</surname>
              <given-names>CE</given-names>
            </name>
          </person-group>
          <article-title>Recurrent meningioma. Salvage therapy with long-acting somatostatin analogue</article-title>
          <source>Neurology</source>
          <year>2007</year>
          <volume>69</volume>
          <fpage>969</fpage>
          <lpage>73</lpage>
          <pub-id pub-id-type="doi">10.1212/01.wnl.0000271382.62776.b7</pub-id>
          <pub-id pub-id-type="pmid">17785665</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eddleman</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>JK</given-names>
            </name>
          </person-group>
          <article-title>Optic nerve sheath meningioma: current diagnosis and treatment</article-title>
          <source>Neurosurg Focus.</source>
          <year>2007</year>
          <volume>23</volume>
          <fpage>E4</fpage>
          <pub-id pub-id-type="doi">10.3171/FOC-07/11/E4</pub-id>
          <pub-id pub-id-type="pmid">18004966</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adams</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Roos</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Crompton</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Radiotherapy for optic nerve sheath meningioma: a case for earlier intervention?</article-title>
          <source>Clin Oncol.</source>
          <year>2013</year>
          <volume>25</volume>
          <fpage>356</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="doi">10.1016/j.clon.2013.02.004</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Conti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pontoriero</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Midili</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>CyberKnife multisession stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for perioptic meningiomas: intermediate-term results and radiobiological considerations</article-title>
          <source>Springerplus.</source>
          <year>2015</year>
          <volume>4</volume>
          <fpage>37</fpage>
          <pub-id pub-id-type="doi">10.1186/s40064-015-0804-2</pub-id>
          <pub-id pub-id-type="pmid">25674497</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
